Morrison, architecture alumni honored by Arts and Letters academy

Toni Morrison, M.A. '55, and alumni architects J. Meejin Yoon and Eric Höweler are among new recipients of American Academy of Arts and Letters honors.

Tracking the epigenetic evolution of a cancer, cell by cell

A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center researchers enables them to track the molecular evolution of cancers.

Milstein students ‘Collab’ on tech solutions in service projects

Students in the Milstein Program in Technology and Humanity developed a website, created a computer language learning curriculum and engaged in other service projects this spring.

Mozilla co-founder shares vision for future of tech

Mitchell Baker, chairwoman of Mozilla and co-founder of the Mozilla Project, was on campus May 1 to speak with students in the Milstein Program in Technology and Humanity. 

Cornell selects eight Presidential Postdoctoral Fellows

The Cornell Presidential Postdoctoral Fellowship Program, which attracts some of the world’s best young talent to Cornell, has chosen eight new fellows.

AAP instructors’ Chisholm monument to rise in Brooklyn

A monument honoring Shirley Chisholm designed by two AAP instructors, both alumni, will soon rise in Brooklyn and is the first of five monuments that will honor women who’ve made an impact on New York City.

Public Theater director: ‘Use theater to cross boundaries’

Oskar Eustis, artistic director of the Public Theater in New York City, was at Cornell April 24 for a visit sponsored by the Milstein Program in Technology and Humanity. His talk was titled “Theater and Democracy.”

‘Oculi’ 2.0 faculty collaboration to open at new site May 25

Oculi, a sculptural pavilion by architecture, art and engineering faculty at Cornell, will move this spring from New York City to Art Omi, an art organization in Ghent, New York.

Discovery reveals potential pathway for treating obesity

A discovery by researchers at Weill Cornell Medicine has revealed that a molecule produced in stem-like cells may be therapeutic targets for obesity and related disorders.